Daniel Sullivan is Bupa’s Director of Product, Proposition and Transformation for UK Insurance. Since joining Bupa, Daniel has worked on several initiatives including: Well+, Connected Care, our SME growth strategy, genomics and most recently is part of the later living (Project Owl) working group.
Daniel joined Bupa UK in 2021 from KPMG UK where we held a variety of roles, including Director of KPMG’s Marketing Centre of Expertise. Daniel’s career has focussed on marketing and proposition management in financial services, including roles at Lloyds Banking Group and Unum.
Daniel lives in Wiltshire and has a degree in Communication Studies from the University of the West of England alongside professional qualifications from the Chartered Institute of Insurance and Chartered Institute of Marketing.
Matt Confeld is Director of Clinical Research Methodology at Worldwide Clinical Trials, with over 12 years of experience in the pharmaceutical sciences. In his current role, Matt supports biotech companies by guiding their strategic regulatory, program design, and commercialization initiatives. Throughout his career, he has successfully navigated dozens of clinical-stage oncology programs from First-in-Human (FIH) trials through Phase 3. Matt’s foundational scientific expertise is rooted in clinical pharmacogenomics and the pre-clinical drug development of nanoparticles across multiple solid tumors. Matt also actively bridges the gap between the laboratory and the clinic by serving as a translational research advisor to an NIH pancreatic cancer research center.
AmeriPouch is a modern U.S.-based contract manufacturer focused on innovative nicotine and supplement pouch solutions. We are building scalable, compliant, and market-ready formats for today’s fast-moving CPG brands.
-Simplifying production for nicotine brands in the U.S. and internationally with a domestic facility
-Developing nicotine, nootropic, and supplement pouches with custom formulations
-Creating proprietary flavor systems and advanced actives delivery tech
-Partnering with brands to prototype, manufacture, and scale new SKUs -Running turnkey operations including R&D, compliance, and fulfillment
-Bringing 20+ years of formulation and flavor expertise to next-gen delivery formats
Mr. Waqas Khan is a senior executive with over 20 years of prolific experience leading global rollouts for Fortune 500 companies, including British American Tobacco (BAT), Juul Labs, Etisalat, Telenor, and Ooredoo. His expertise spans multiple sectors, including consumer packaged goods, telecommunications, mobile devices, broadband, med-tech, and fintech. He has successfully launched and scaled brands across three continents, building high-performing teams and driving business growth on a global scale.
In addition to his corporate leadership, Mr. Khan is a serial entrepreneur who has co-founded three startups. The most recent, LIX Innovations Inc., was acquired by ITG Brands USA in a multimillion-dollar deal in 2023. Currently, he serves as the Global CEO of CLEW Pouches, a revolutionary nicotine pouch, accepted by the FDA for its innovative approach to harm reduction.
Daren is a Vice-President in CGI’s UK Insurance business, leading a consulting team working with clients to shape digital strategy, modernise business models, and apply emerging technologies to deliver measurable outcomes. With over 30 years’ experience in the London and General Insurance markets, Daren brings deep industry expertise alongside more than a decade in InsurTech, consulting and technology delivery. He applies a pragmatic approach in the use of technology to make a difference for the business, focusing on a lean, rapid approach to transformation and the value it creates for people. Daren is passionate about approaching complex challenges differently and believes that traditional transformation does not meet the needs of modern business. He partners with senior business and technology leaders to bridge the gap between innovation and reality, to ensure solutions are focused on real value not technology hype.
Arno Ružička, project manager, is a graduate electrical engineer and expert in industrial automation with over 15 years of experience. He specializes in developing and implementing software solutions that modernize industrial processes, particularly in the brewing and food industries, as well as across other manufacturing sectors.
Pablo Cano Trilla leads the legal analysis team at Tamarind Intelligence (publisher of ECigIntelligence and TobaccoIntelligence), overseeing regulatory coverage across more than 100 countries, U.S. states, and other subnational jurisdictions.
He holds a Master of Laws (LLM) with Distinction from the University of Aberdeen and degrees in law and political science. Pablo began his career as an assistant at the European Parliament and has since built an international legal career, working as a lawyer and legal analyst in Mexico, the UK, and Spain, specializing in highly regulated industries. He is a qualified attorney.
For over a decade, Pablo has provided independent, in-depth legal and political analysis on the tobacco and nicotine industries to clients including international corporations, governments, tobacco control NGOs, and academic institutions. A seasoned speaker, he has delivered numerous presentations and conferences on key industry issues to diverse global audiences.
